Keywords: Galena Biopharma, Teva, NeuVax, Nelipepimut-S, Israel, Breast cancer vaccine

Galena Biopharma leaps on deal with Teva for NeuVax in Israel

Article | 05 December 2012

Print This

Shares of US biotech firm Galena Biopharma (Nasdaq: GALE) leapt 13.7% to $2.32 in pre-market trading yesterday, when the company revealed it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in